TERNS PHARMACEUTICALS INC (TERN)

US8808811074 - Common Stock

4.57  -0.23 (-4.79%)

After market: 4.7 +0.13 (+2.84%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
0.000.000.001.00M0.00
Minority Interest Expense
N/AN/AN/A0.00520.00K
Operating Expenses
99.98M102.56M62.03M50.86M37.03M
Research and Development
69.57M63.50M39.62M31.31M28.03M
Selling, General, and Administrative Expenses
30.41M39.06M22.41M19.55M9.00M
Operating Income
-99.98M-102.56M-62.03M-49.86M-37.03M
Interest Income/Expense
12.48M12.90M2.11M170.00K60.00K
Other Income/Expense
-303.00K-314.00K-70.00K40.00K-2.79M
Income Before Taxes
-87.80M-89.97M-59.99M-49.65M-39.76M
Income Tax
269.00K239.00K360.00K510.00K810.00K
Net Income
-88.07M-90.21M-60.35M-50.16M-29.35M
EBITDA
-99.66M-102.27M-61.55M-49.35M-36.64M
 
Per Share Data
EPS Diluted Total Ops
-1.18-1.27-1.67-2.21-1.29
Non GAAP EPS
-1.18-1.27-1.83-2.34N/A
 
Statistics
Profit Margin
N/AN/AN/A-5016.00%N/A
Operating Profit Margin
N/AN/AN/A-4986.00%N/A

All data in USD

Charts